Synch advised Innovestor Life Science Fund and Hadean Ventures on the deal. Gesynta Pharma completed a SEK 304 million funding round. The SEK 304 million secured...
Gesynta Pharma’s Investment Round
Grängesberg Exploration Holding AB’s SEK1,9 Billion Development of Dannemora Iron AB
Synch assisted Grängesberg Exploration Holding AB (publ) through out the planning and execution of the bid process and completion of the contracts. Grängesberg Exploration Holding AB...